Ashley Hughes
Nurse Practitioner · Fort Wayne, INNPI 1912486689
Payments from drug & device makers
Across 149 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$476
- Lilly USA, LLC$406
- AbbVie$390
- Novo Nordisk$251
- Boehringer Ingelheim$214
- Exact Sciences$211
- plus $646 from 11 others
What the payments were for
- Food & beverage$2,593100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $476 |
| Lilly USA, LLC | 26 | $406 |
| AbbVie | 30 | $390 |
| Novo Nordisk | 16 | $251 |
| Boehringer Ingelheim | 12 | $214 |
| Exact Sciences | 11 | $211 |
| Axsome Therapeutics, Inc. | 9 | $208 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $118 |
| GSK | 4 | $68 |
| Astellas Pharma US Inc | 3 | $67 |
| Amgen | 3 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Pfizer | 2 | $27 |
| Lundbeck LLC | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
How this compares
$2,593 in reported general payments places this provider in the 85th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 61 | $70,066 |
| OzempicSemaglutide | 35 | $55,230 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $33,035 |
| MounjaroTirzepatide | 23 | $29,280 |
| JanuviaSitagliptin Phosphate | 19 | $25,082 |
| EliquisApixaban | 20 | $20,303 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $18,412 |
| JanumetSitagliptin Phos/Metformin Hcl | 20 | $16,824 |
| FarxigaDapagliflozin Propanediol | 16 | $16,570 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $15,530 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 17 | $13,243 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $9,971 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $4,047 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,783 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 88 | $2,309 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat | $214 | $93,28093 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $68 | $55,49464 claims |
| Novo NordiskOzempic | $251 | $55,23035 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $476 | $32,10037 claims |
| Lilly USA, LLCMounjaro | $406 | $29,28023 claims |
| PfizerEliquis | $27 | $20,30320 claims |
| AbbVieSynthroid | $390 | $38611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Fort Wayne
- Sean GoddardFort Wayne$180K
- Kristine TaylorFort Wayne$69K
- Mary BullisFort Wayne$27K
- Nathan MinerFort Wayne$21K
- Joel NagelFort Wayne$20K
- Gabriela NorthFort Wayne$18K
- Karen LothamerFort Wayne$12K
- Pamela ShodaFort Wayne$11K
- Sara CoburnFort Wayne$9K
- Marlise FletterFort Wayne$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.